Amgen Soars After CEO Gives Update on Experimental Obesity Drug bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
(Bloomberg) Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineApple Rallies Most in 18 Months on Upbeat Forecast, BuybackEverything Apple Plans to Show at May 7 ‘Let Loose’ iPad EventTrump Auditions VP Picks Before Wealthy Donors in Palm BeachTurkey Confirms All Trade Halt With Israel